Design and synthesis of novel diphenyl oxalamide and diphenyl acetamide derivatives as anticonvulsants

Archiv der Pharmazie

Volumn 345, Issue 1, 2012, Pages 57-64

  Nikalje, Anna Pratima G ^a   Ghodke, Mangesh ^a   Girbane, Amol ^a  

^a Y B CHAVAN COLLEGE OF PHARMACY   (India)

Author keywords

Anticonvulsant; Chloroacetyl chloride; Diphenyl amine; MES; ScPTZ

Indexed keywords

2 (2 HYDROXYPHENYLAMINO) N,N DIPHENYLACETAMIDE; 2 (4 CHLOROPHENYLAMINO) N,N DIPHENYLACETAMIDE; 2 (4 HYDROXYPHENYLAMINO) N,N DIPHENYLACETAMIDE; 2 (O TOLYLAMINO) N,N DIPHENYLACETAMIDE; 2 CHLORO N,N DIPHENYLACETAMIDE; 4 [(DIPHENYLCARBAMOYL)METHYL AMINO]BENZOIC ACID; 4 [2 (DIPHENYLAMINO) 2 OXOACETAMIDO]BENZOIC ACID; AMIDE; ANTICONVULSIVE AGENT; N1 (2 HYDROXYPHENYL) N2,N2 DIPHENYLOXALAMIDE; N1 DIPHENYL N2,N2 (PYRIMIDIN 2 YL)OXALAMIDE; N1,N1 DIPHENYL N2 PARA TOLYLOXAMIDE; N1,N1 DIPHENYL N2,N2 O TOLYLOXAMIDE; PENTETRAZOLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ANTICONVULSANT THERAPY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SEIZURE;

ACETAMIDES; ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; DIPHENYLACETIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; FEMALE; MALE; MICE; MOLECULAR STRUCTURE; MOTOR ACTIVITY; NEUROTOXICITY SYNDROMES; OXAMIC ACID; SEIZURES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84855703063     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.201100108     Document Type: Article

References (14)

1. P. Yogeeswari, D. Sriram, J. V. Ragavendran, R. Thirumurugan, Curr. Drug Metab. 2005, 6, 127-139.
2. M. A. Aziz, G. El-Din, A. A. Hassan, Eur. J. Med. Chem. 2009, 44, 3480-3487.
3. J. Awapara, A. J. Landua, R. Fuerst, B. Seale, J. Bio. Chem. 1950, 187, 35-39.
4. K. F. Killam, J. Pharmacol. Exp. Ther. 1957, 119, 263-271.
5. D. R. Curtis, J. W. Phillis, J. C. Watkins, J. Physiol. 1959, 146, 185-203.
6. E. Toth, A. Lajhta, S. Sarhan, N. Seiler, Neurochem. Res. 1983, 8, 291-302.
7. P. Yogeeswari, J. V. Ragavendran, D. Sriram, Drug Discovery 2006, 1, 113-118.
8. J. G Cannon, M. E. Wolff, (Eds.), Burger's Medicinal Chemistry and Drug Discovery, Wiley, New York 1995, pp. 783-798.
9. V. R. Jegadeesan, S. Dharmarajan, S. Kotapati, J. Stables, P. Yogeeswary, Eur. J. Med. Chem. 2008, 43, 146-152.
10. M. S. Dunham, T. A. Miya, J. Am. Pharm. Assoc. Sci. 1957, 46, 208-209.
11. S. K. Kulkarni, Handbook of Experimental Pharmacology, (3rd Ed.) Vallabh Prakashan, New Delhi 1999, p. 117.
12. V. Jatav, P. Mishra, S. Kashaw, J. Stables, Eur. J. Med. Chem. 2008, 43135-43141.
13. K. K. Agrawal, V. Lata, K. Saxena, Eur. J. Chem. 2006, 41, 1223-1229.
14. A. V. Shindikar, F. Khan, C. L. Vishwanathan, Eur. J. Med. Chem. 2006, 41, 186-792.